ClinVar Miner

Submissions for variant NM_001040142.2(SCN2A):c.1270G>A (p.Val424Met)

dbSNP: rs1574567728
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000818571 SCV000959191 pathogenic Seizures, benign familial infantile, 3; Developmental and epileptic encephalopathy, 11 2020-01-17 criteria provided, single submitter clinical testing This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN2A protein function. This variant has been observed in individual(s) with early-onset epileptic encephalopathy with Rett-like features (PMID: 28709814). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 661206). This sequence change replaces valine with methionine at codon 424 of the SCN2A protein (p.Val424Met). The valine residue is highly conserved and there is a small physicochemical difference between valine and methionine.
3billion RCV003152737 SCV003841878 pathogenic Developmental and epileptic encephalopathy, 11 2023-02-23 criteria provided, single submitter clinical testing The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.80; 3Cnet: 1.00). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with SCN2A related disorder (ClinVar ID: VCV000661206 / PMID: 28709814). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
GeneDx RCV004702452 SCV005201292 pathogenic not provided 2023-05-26 criteria provided, single submitter clinical testing Missense variants in this gene are often considered pathogenic (HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This substitution is predicted to be within the C-terminal cytoplasmic domain; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28709814, Liang2018[noPMID])

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.